Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ringer Acetate Del Nido vs HTK in CABG
NCT06414330Phase 3Completed
- Sponsor
- Assiut University
- Start
- Jun 2024
- Primary completion
- Nov 2025
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ringer acetate based del Nido cardioplegia in cardiac ischemia, sponsored by Assiut University. Primary endpoint: Any arrhythmia other than sinus rhythm after cross-clamp removal and reperfusion. Started Jun 2024; status: completed.
02
Drugs
ringer acetate based del Nido cardioplegia
03
Conditions
cardiac ischemia
Beyond the preview
Go deeper on NCT06414330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06414330.